Cargando…
Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Cancer is one of the most fatal diseases with an increasing incidence and mortality all over the world. Thus, there is an urgent need for novel therapies targeting major cancer-related pathways. Nuclear factor-erythroid 2-related factor 2 (NRF2) and its major negative modulator Kelch-like ECH-associ...
Autores principales: | Telkoparan-Akillilar, Pelin, Panieri, Emiliano, Cevik, Dilek, Suzen, Sibel, Saso, Luciano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7961421/ https://www.ncbi.nlm.nih.gov/pubmed/33808001 http://dx.doi.org/10.3390/molecules26051417 |
Ejemplares similares
-
The NRF2/KEAP1 Axis in the Regulation of Tumor Metabolism: Mechanisms and Therapeutic Perspectives
por: Panieri, Emiliano, et al.
Publicado: (2020) -
Potential Applications of NRF2 Modulators in Cancer Therapy
por: Panieri, Emiliano, et al.
Publicado: (2020) -
Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs
por: Telkoparan-Akillilar, Pelin, et al.
Publicado: (2019) -
An Overview of NRF2-Activating Compounds Bearing α,β-Unsaturated Moiety and Their Antioxidant Effects
por: Egbujor, Melford Chuka, et al.
Publicado: (2022) -
Potential Applications of NRF2 Inhibitors in Cancer Therapy
por: Panieri, Emiliano, et al.
Publicado: (2019)